Clinical trials
Phase 2 Major Depressive Disorder trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| University Health Network, Toronto | 4 |
| Centre for Addiction and Mental Health | 2 |
| H. Lundbeck A/S | 2 |
| Boehringer Ingelheim | 1 |
| Brain and Cognition Discovery Foundation | 1 |
| BrainCells Inc. | 1 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
| Cybin Therapeutics Inc. | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 32 |
| Depressive Disorder | 7 |
| Mood Disorders | 6 |
| Depressive Disorder, Treatment-Resistant | 5 |
| Mental Disorders | 5 |
| Anxiety Disorders | 2 |
| Bipolar Disorder | 2 |
| Alcoholism | 1 |
| Borderline Personality Disorder | 1 |
| Disorders of Excessive Somnolence | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.